University of Maryland
Background data
Program Type : Adult ProgramFACT Approved: Yes
Year CAR T-cell Therapy Program Opened:
Location Info
University of Maryland22 S. Green St.
Baltimore, , 21201
Baltimore, , 21201
Website : https://www.umms.org/umgccc/cancer-services/cancer-care/blood-marrow-transplant
CAR T-cell therapies performed
Numbers displayed are the most recent data provided by this center.| Year | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Number performed | - | - | - | - | - |
Program Director
| Name | Phone |
|---|---|
| Taofeek Owonikoko, MD, PhD |
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Breyanzi (lisocabtagene maraleucel, liso-cel)
- Carvykti (ciltacabtagene autoleucel, cita-cel)
- Kymriah (tisagenlecleucel, tisa-cel)
- Tecartus (brexucabtagene autoleucel, brexu-cel)
- Yescarta (axicabtagene ciloleucel, axi-cel)